U.S. Markets closed

Rosetta Genomics Ltd. (ROSG)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.36-0.07 (-4.90%)
At close: 4:00PM EDT
People also watch
RXIICLSNPSTIOPXACYCC
  • J
    Jason
    Jason

    I will clear this up for you. $ROSG is an Israeli company. They file earnings TWICE yearly, as per their foreign-based reporting requirements. Once at end of March, once at end of September. Earnings will be out next week. I expect very solid Reveal sales. In next week's semi-annual report I expect Kenny will update us on patent developments. There have been a number of them. fully diluted share count is under 7M shares. Fully diluted MC is less than $10M. They will do more than $10M this year in revenues. Reveal revenues expected to increase from $800k last year to $4,000,000+ this year. That is crazy growth. Reveal could challenge $VCYT indeterminate thyroid nodule test Afirma, which does $16,000,000 in revenues per quarter, or $64,000,000 a year. ROSG has nearly no debt, MC of less than $10M fully diluted, growing revenues north of $10M annually, just increased its cash position, and could be cash flow positive easily by next year, with growing Reveal sales. Plus has a treasure trove of patents for using microRNA sequencing as a diagnostic for all sorts of indications (thyroid, gastric, ovarian, even Alzheimers patent pending). Finally, they appear to have reached agreement with Clinical Pathology Laboratories https://www.cpllabs.com/ to use Reveal indeterminate thyroid test exclusively in their network of hundreds of physicians.

  • J
    Jason
    Jason
    "Subject to our achieving quarterly RosettaGX Reveal sales milestones." "We anticipate the notes would mature 3 years after issuance." Quarterly sales milestones - 3-year maturity date on the notes - this is a legitimate investor, IMO. Hoping for Morgan! I wouldn't be surprised if Morgan has poured over the facts and believes Reveal with become SoC over $VCYT Afirma & $IDXG ThyraMIR. Wouldn't be surprised if Morgan also agrees that $IDXG ThryraMIR violating Rosetta's 9,650,679 and 9,650,680 patents as well. $ROSG has informed $IDXG they believe $IDXG's ThyraMIR is in violation of these patents.
  • J
    Jason
    Jason

    $ROSG $ALNY $IONS an absolute must read https://seekingalpha.com/article/197638-rosetta-genomics-giving-isis-and-alnylam-a-run-for-their-mirnas

    Rosetta Genomics: Giving Isis and Alnylam a Run for Their miRNAs?
    In late 2007, Isis Pharmacueticals (ISIS) and Alnylam Pharmaceuticals (NASDAQ:ALNY) created a joint venture, operated as an independent company, called Regulus
    seekingalpha.com
  • J
    Jake
    Jake
    Pump and dump with NO product to sell! I know what I am talking about here! Get out while you can!
  • J
    Jason
    Jason
    Although a blip on the radar for them, Morgan Stanley has increased its position in $ROSG over last two quarters and is now a 5% holder. How crazy would it be if the private placement deal for $10,900,000 currently on the table is with a Morgan Stanley institutional investment fund? It actually would kinda make sense, because we all know that if Morgan Stanley owned, say, 10% or more of the stock right now the price would be far higher.
  • J
    Jason
    Jason
    Morgan Stanley only has 8% of their investments in healthcare, so the fact that they have an investment in $ROSG at all, no less a 5% stake, is extremely intriguing, IMO.
  • J
    Jason
    Jason
    "$ROSG has capturing 50% of the current intellectual property (IP) surrounding commercial use of microRNA’s ... "the other major player in this field is ISIS and Alnylam Pharmaceuticals, having captured most of the remaining IP space."
  • J
    Jason
    Jason
    I have shared a lot of my thoughts on $ROSG on the $ROSG Stocktwits page. I am Turquoise. Following along if your interested. I would link to it here but I think links aren't allowed.
  • M
    Megan
    Megan

    In the short-term ROSG does not seem to be like a good trade. Yo you should really check out https://activepennystocks1.blogspot.com, they seem on point with their stocks.

  • L
    Littleguy
    Littleguy
    We have volume and share price climbing. Still not to the $1.70 secondary price, but up is good.
  • J
    Jake
    Jake
    Just FYI but CFO was the CFO of Toys R US! Just look what happened to them! Busted Pedro!
  • G
    Guerilla Trades
    Guerilla Trades
    Strong buying here. Long!
  • m
    michael
    michael
    so. no .bews seeking alpha lied..but 3m volume could spell then end
  • m
    michael
    michael
    ha what a sham. shabby at its best
  • m
    michael
    michael
    this must be the end. 550 shares. now we break a dollar
  • G
    Guerilla Trades
    Guerilla Trades
    long again here.
  • h
    hqpwwkwr
    hqpwwkwr

    The dork has improved my trading times 10. See for yourself at https://greatprofit12.blogspot.com/

    Penny Stocks
    greatprofit12.blogspot.com
  • m
    michael
    michael
    they only raised 4million dollars. will dilute again.or done
  • J
    Justin
    Justin
    woah volume